SAMBHV evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-30T14:01:22.895035+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 24132430000.0
- net_income
- 1421510000.0
- operating_cash_flow
- 1724710000.0
- free_cash_flow
- -1140930000.0
- total_assets
- 20657050000.0
- total_liabilities
- 10120980000.0
- total_equity
- 10536070000.0
- cash
- 842090000.0
- total_debt
- 3733410000.0
- revenue_growth
- 0.5967413347625143
- earnings_growth
- 1.4823365057190254
- net_margin
- 0.05890455291903882
- roe
- 0.13491842783884314
- debt_to_equity
- 0.3543455956537874
- cash_conversion
- 1.2132943137930792
- free_cash_flow_margin
- -0.047277874627627635
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-6c6b848cf591f5a37329884a2e20cf7456c9a2be629d8124f0ef5fe93de8b94e
- Policy
- stock-decisions-v1
- Evidence bundle hash
- b7fe3ab1a11eab51a84d643845a69d8b2db75d6e2875e9753a1a17c30ff475d3
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 112327dd1526b7a2ee712845b22e819d916ebefc7369c5c55ad64f4531f3562c
- daily-price: 01da1527d0ef0e9edf2c890902909ec4eee6f979ddd46eed0da5e2e1221ac79f
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 161.45.
- The trailing 5-session price return was 5.97%.
- The trailing 20-session price return was 27.95%.
- The trailing 60-session price return was 41.15%.
- The trailing 250-session price return was 40.88%.
- Average cached traded value over twenty sessions was INR 1,124,147,764.
- The closing price was -2.09% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-30T14:01:22.895035+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.5967413347625143.
- The cached financial metric net margin is 0.05890455291903882.
- The cached financial metric roe is 0.13491842783884314.
- The cached financial metric debt to equity is 0.3543455956537874.
- The cached financial metric cash conversion is 1.2132943137930792.
- The cached financial metric free cash flow margin is -0.047277874627627635.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.